| EMA number | EMEA/H/C/002303 |
| ATC code | B01AC24 |
| Authorisation | 3 December 2010 |
| Withdrawn | 27 March 2013 |
| Revision | 2 |
Possia, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndromes (unstable angina, non-ST-elevation myocardial infarction [NSTEMI] or ST-elevation myocardial infarction [STEMI]); including patients managed medically, and those who are managed with percutaneous coronary intervention (PCI) or coronary artery by-pass grafting (CABG).